Vice President of Enzyme and Strain Development, Curie Co
Ute Galm is a molecular microbiologist with 10+ years of experience in strain engineering, synthetic biology, and industrial biotechnology and is the Vice President of Enzyme and Strain Development at Curie Co. After more than a decade in R&D and product development, Ute believes it is critical to wisely use what nature provides to us in the development of sustainable solutions to protect humanity and to preserve our planet. Before joining Curie Co, Ute was an Associate Director at Zymergen, a company that integrates automation, machine learning, and genomics to rapidly accelerate the pace of scientific advancement. Prior to joining Zymergen, Ute worked as a scientist and group leader at Dow AgroSciences on the development of fermentation derived insecticide and fungicide products. She graduated from the University of Tuebingen, Germany with a PhD degree in Pharmaceutical Biology and received her postdoctoral training at the University of Wisconsin at Madison. Ute is passionate about all aspects of using biology to develop sustainable solutions for human health and other market applications. Ute can be reached at firstname.lastname@example.org.